Jerman A Michael - 08 Feb 2024 Form 3 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
Director
Signature
/s/ Nathen Fuentes, Attorney-in-Fact for Hugh McColl, III
Issuer symbol
TELO
Transactions as of
08 Feb 2024
Net transactions value
$0
Form type
3
Filing time
08 Feb 2024, 17:52:41 UTC
Previous filing
20 Nov 2023
Next filing
27 Mar 2024

No securities are beneficially owned.